Search results
Results from the WOW.Com Content Network
Johnson & Johnson (J&J) is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange.
In 1959, the contact business unit started as Frontier Contact Lenses in Buffalo, New York. [3]The surgical business unit started when implantable medical device company Heyer-Schulte Co., started a ophthalmic research division, named Heyer-Schulte Medical Optics Center (HSMOC), focusing on aphakic lenses and extended-wear cosmetic contact lenses.
In May 2015, Artisan Partners called for The Adecco Group to reconsider appointing Alain Dehaze as its CEO. [17]In January 2016, Artisan Partners called for Johnson & Johnson to consider separating its three divisions, consumer products, pharmaceuticals and medical devices into standalone companies.
In 1961, Janssen Pharmaceuticals was purchased by New Jersey–based American corporation Johnson & Johnson, and became part of Johnson & Johnson Pharmaceutical Research and Development (J&J PRD), now renamed to Janssen Research and Development (JRD), which conducts research and development activities related to a wide range of human medical ...
Abiomed, Inc. is a medical device technology company that operates as a stand-alone business within Johnson & Johnson's MedTech Segment. [2] Abiomed develops and manufactures temporary external and implantable mechanical circulatory support devices.
The chairman of J&J at the time was instrumental in the plan. [ 9 ] [ 4 ] [ 5 ] While New Brunswick lost many historic structures, including the early home of Rutgers University, and most of its historic commercial waterfront to the redevelopment effort, the gentrification did attract people back to New Brunswick.
A securities class action was initiated in the United States District Court of New Jersey by law firm Kessler Topaz Meltzer & Check, LLP on 9 October 2023. The action alleged that Kenvue was in violation of federal securities laws - having made fraudulent and misleading statements, including omissions, about the company's internal control and financial reporting.
James Edward Burke (February 28, 1925 – September 28, 2012) [1] was an American businessman who was the chief executive officer (CEO) of Johnson & Johnson (J&J) from 1976 to 1989, where he worked for forty years. [2] [3] The company's revenue tripled to more than $9 billion under his tenure. [4]